2021
DOI: 10.1021/acsami.1c10898
|View full text |Cite
|
Sign up to set email alerts
|

3D-Printed Multifunctional Polyetheretherketone Bone Scaffold for Multimodal Treatment of Osteosarcoma and Osteomyelitis

Abstract: In this work, we developed the first 3D-printed polyetheretherketone (PEEK)-based bone scaffold with multi-functions targeting challenging bone diseases such as osteosarcoma and osteomyelitis. A 3D-printed PEEK/graphene nanocomposite scaffold was deposited with a drug-laden (antibiotics and/or anti-cancer drugs) hydroxyapatite coating. The graphene nanosheets within the scaffold served as effective photothermal agents that endowed the scaffold with on-demand photothermal conversion function under near-infrared… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
28
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 52 publications
(28 citation statements)
references
References 53 publications
(84 reference statements)
0
28
0
Order By: Relevance
“…Various concentrations (0, 10, 20, 40 and 60 µmol/l) of HGK were applied to treat hFOB 1.19 cells to test the safety of the drug. In addition, MG-63 and U2OS cells were also treated with various concentrations of HGK (10,20,40 and 60 µmol/l) for 48 h, and assigned as the treatment groups. Moreover, MG-63 and U2OS cells as well as hFOB 1.19 cells received 0 µmol/l HGK and were assigned as the control groups.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Various concentrations (0, 10, 20, 40 and 60 µmol/l) of HGK were applied to treat hFOB 1.19 cells to test the safety of the drug. In addition, MG-63 and U2OS cells were also treated with various concentrations of HGK (10,20,40 and 60 µmol/l) for 48 h, and assigned as the treatment groups. Moreover, MG-63 and U2OS cells as well as hFOB 1.19 cells received 0 µmol/l HGK and were assigned as the control groups.…”
Section: Methodsmentioning
confidence: 99%
“…In recent years, with the development of tissue engineering, increasing attention has been paid to the development of bone substitutes with custom-made microarchitecture and physicomechanical properties comparable to native bone, such as bioactive three-dimensional (3D) porous polymer or ceramic scaffolds or its conjugated forms, which can mimic the host tissue to facilitate the transferring of nutrients to ensure defective bone restoration (7)(8)(9). Moreover, 3D-printed multifunctional polyetheretherketone bone scaffold was widely applied in the multimodal treatment of osteosarcoma and osteomyelitis (10). clinical results reveal that the efficacy of current chemotherapy drugs in patients with metastatic osteosarcoma is insufficient (11).…”
Section: Introductionmentioning
confidence: 99%
“…It is worth mentioning that some macromolecular nanomaterials composed of nanoparticles (such as nanosheets, nanotubes, mesoporous materials, etc.) are often used as nanoplatforms to carry drugs to treat diseases ( Yan J. et al, 2021 ; Wang Y.-C. et al, 2021 ; Zhu et al, 2021 ). To date, nanomaterials have been widely used in various fields of medical treatment ( Zhu et al, 2018 , 2019 ).…”
Section: Hydrogelsmentioning
confidence: 99%
“…Resect the malignant lesions through surgery is the first treatment option for tumors without extensive metastatic lesions, while palliative therapy is the optimal choice for terminal cancer [ 2 ]. Implants are widely used in both cases, they can fill the surgical site resulting from the tumor resection surgery [ 3 , 4 ]. Or as a stent to alleviate malignant obstruction in the palliative treatment [ 5 , 6 ].…”
Section: Introductionmentioning
confidence: 99%